Search research articles
Contact Us
Filters
Showing results (51-60 of 168) with videos related to
Page
of 17
Sort By:
Expert Review of Anti-Infective Therapy
|
September 7, 2021
An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of infection-related ventilator associated complications (IVACs) caused by Enterobacterales in critically ill adult patients
Milo Gatti, Bruno Viaggi, Gian Maria Rossolini, et al.
Pharmaceutics
|
January 28, 2026
Two Comprehensive Liquid Chromatography High-Resolution Mass Spectrometry (UPLC-MS/MS) Multi-Methods for Real-Time Therapeutic Drug Monitoring (TDM) of Five Novel Beta-Lactams and of Fosfomycin Administered by Continuous Infusion
Ilaria Trozzi, Beatrice Giorgi, Riccardo De Paola, et al.
Antibiotics (Basel, Switzerland)
|
January 21, 2022
An Evidence-Based Multidisciplinary Approach Focused on Creating Algorithms for Targeted Therapy of Infection-Related Ventilator-Associated Complications (IVACs) Caused by <i>Pseudomonas aeruginosa</i> and <i>Acinetobacter baumannii</i> in Critically Ill Adult Patients
Milo Gatti, Bruno Viaggi, Gian Maria Rossolini, et al.
Drug Safety
|
September 26, 2019
Comparative Effectiveness and Safety of Direct Oral Anticoagulants: Overview of Systematic Reviews
Emanuel Raschi, Matteo Bianchin, Milo Gatti, et al.
Pharmaceutics
|
March 28, 2026
Accurate and Sensitive UHPLC-Tandem Mass Spectrometry Sequential Methods for Therapeutic Drug Monitoring of Aztreonam/Avibactam in Human Plasma
Ilaria Trozzi, Beatrice Giorgi, Riccardo De Paola, et al.
The Journal of Antimicrobial Chemotherapy
|
October 15, 2020
Ceftolozane/tazobactam exposure in critically ill patients undergoing continuous renal replacement therapy: a PK/PD approach to tailor dosing
Milo Gatti, Maddalena Giannella, Emanuel Raschi, et al.
Infection and Drug Resistance
|
July 8, 2021
An Evidence-Based Multidisciplinary Approach Focused at Creating Algorithms for Targeted Therapy of BSIs, cUTIs, and cIAIs Caused by <i>Enterobacterales</i> in Critically Ill Adult Patients
Milo Gatti, Bruno Viaggi, Gian Maria Rossolini, et al.
Frontiers in Pharmacology
|
December 27, 2021
Development of a Network-Based Signal Detection Tool: The COVID-19 Adversome in the FDA Adverse Event Reporting System
Michele Fusaroli, Emanuel Raschi, Milo Gatti, et al.
Microorganisms
|
February 25, 2023
Targeted Therapy of Severe Infections Caused by <i>Staphylococcus aureus</i> in Critically Ill Adult Patients: A Multidisciplinary Proposal of Therapeutic Algorithms Based on Real-World Evidence
Milo Gatti, Bruno Viaggi, Gian Maria Rossolini, et al.
Vaccines
|
January 7, 2021
Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase
Milo Gatti, Emanuel Raschi, Ugo Moretti, et al.
Page
of 17
Search research articles
Search
Showing results (51-60 of 168) with videos related to
Sort By:
Page
of 17
Expert Review of Anti-Infective Therapy
|
September 7, 2021
An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of infection-related ventilator associated complications (IVACs) caused by Enterobacterales in critically ill adult patients
Milo Gatti, Bruno Viaggi, Gian Maria Rossolini, et al.
Pharmaceutics
|
January 28, 2026
Two Comprehensive Liquid Chromatography High-Resolution Mass Spectrometry (UPLC-MS/MS) Multi-Methods for Real-Time Therapeutic Drug Monitoring (TDM) of Five Novel Beta-Lactams and of Fosfomycin Administered by Continuous Infusion
Ilaria Trozzi, Beatrice Giorgi, Riccardo De Paola, et al.
Antibiotics (Basel, Switzerland)
|
January 21, 2022
An Evidence-Based Multidisciplinary Approach Focused on Creating Algorithms for Targeted Therapy of Infection-Related Ventilator-Associated Complications (IVACs) Caused by <i>Pseudomonas aeruginosa</i> and <i>Acinetobacter baumannii</i> in Critically Ill Adult Patients
Milo Gatti, Bruno Viaggi, Gian Maria Rossolini, et al.
Drug Safety
|
September 26, 2019
Comparative Effectiveness and Safety of Direct Oral Anticoagulants: Overview of Systematic Reviews
Emanuel Raschi, Matteo Bianchin, Milo Gatti, et al.
Pharmaceutics
|
March 28, 2026
Accurate and Sensitive UHPLC-Tandem Mass Spectrometry Sequential Methods for Therapeutic Drug Monitoring of Aztreonam/Avibactam in Human Plasma
Ilaria Trozzi, Beatrice Giorgi, Riccardo De Paola, et al.
The Journal of Antimicrobial Chemotherapy
|
October 15, 2020
Ceftolozane/tazobactam exposure in critically ill patients undergoing continuous renal replacement therapy: a PK/PD approach to tailor dosing
Milo Gatti, Maddalena Giannella, Emanuel Raschi, et al.
Infection and Drug Resistance
|
July 8, 2021
An Evidence-Based Multidisciplinary Approach Focused at Creating Algorithms for Targeted Therapy of BSIs, cUTIs, and cIAIs Caused by <i>Enterobacterales</i> in Critically Ill Adult Patients
Milo Gatti, Bruno Viaggi, Gian Maria Rossolini, et al.
Frontiers in Pharmacology
|
December 27, 2021
Development of a Network-Based Signal Detection Tool: The COVID-19 Adversome in the FDA Adverse Event Reporting System
Michele Fusaroli, Emanuel Raschi, Milo Gatti, et al.
Microorganisms
|
February 25, 2023
Targeted Therapy of Severe Infections Caused by <i>Staphylococcus aureus</i> in Critically Ill Adult Patients: A Multidisciplinary Proposal of Therapeutic Algorithms Based on Real-World Evidence
Milo Gatti, Bruno Viaggi, Gian Maria Rossolini, et al.
Vaccines
|
January 7, 2021
Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase
Milo Gatti, Emanuel Raschi, Ugo Moretti, et al.
Page
of 17